- Home
- FRPH vs FBRX Comparison
FRPH vs FBRX Comparison
Compare FRPH & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FRPH | FBRX |
|---|---|---|
| Founded | 1986 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 435.3M | 367.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FRPH | FBRX |
|---|---|---|
| Price | $22.79 | $27.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $67.00 |
| AVG Volume (30 Days) | 75.7K | ★ 165.7K |
| Earning Date | 11-05-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $33,049,999.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $93.28 | ★ N/A |
| Revenue Growth | ★ 5.21 | N/A |
| 52 Week Low | $21.68 | $4.90 |
| 52 Week High | $31.99 | $31.27 |
Technical Indicators
Market Signals| Indicator | FRPH | FBRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.35 | 61.96 |
| Support Level | $22.61 | $24.95 |
| Resistance Level | $23.03 | $27.65 |
| Average True Range (ATR) | 0.47 | 2.97 |
| MACD | 0.02 | -0.17 |
| Stochastic Oscillator | 39.61 | 58.39 |
Price Performance
Historical ComparisonAbout FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).